OBJECTIVE: Biweekly surveillance ultrasound (US) examination is a strategy recommended to detect early twin-twin transfusion syndrome (TTTS) in monochorionic-diamniotic (MCDA) twins. However, data to support this frequency of surveillance are scarce. Our objective was to determine whether a biweekly scanning paradigm can reliably detect TTTS at an early stage (i.e. < Quintero stage II). STUDY DESIGN: This is a retrospective cohort study of women with MCDA twin pregnancies whose first US exam occurred at our center between 2012 and 2018. Women with uncertain chorionicity, less than 2 serial US exams, or those followed outside of our healthcare system were excluded. Routine surveillance consisted of an US exam every 2 weeks starting at 16 weeks gestational age (GA). Univariate analysis of US exam patterns and pregnancy characteristics was performed comparing women that had TTTS to those who did not. For women diagnosed after at least one normal US examination, GA and Quintero stage at diagnosis and length of time since the last normal US exam was determined to assess whether the frequency of US examination was adequate. To assess whether the initial screening US was early enough to detect evolving TTTS, women diagnosed with TTTS on their first US were considered separately. RESULTS: Of 409 women with MCDA twins that met inclusion criteria, 46 (11.3%) developed TTTS. Women with TTTS had less time between scans (7.4 AE 7.6 vs. 12.7 AE 8.0 days, p < 0.01), but baseline characteristics were otherwise similar between the groups (Table 1) . Among women with TTTS, 25 (54.4%) were diagnosed at their first US while 21 (46.6%) were diagnosed at a later US. Those diagnosed at the first US had similar GA (20.3 AE 3.8 vs. 22.3 AE 4.9, p ¼ 0.16) and Quintero stage (median II vs. III, p ¼ 0.34) as those diagnosed at a later US exam. The majority of TTTS detected after at a later US (i.e. >1 US) was diagnosed within 2 weeks of the last normal US (16/21, 76%). Most of these twins (9/ 16, 56%, p ¼ 0.09) had stage II or greater disease on diagnosis (Figure 1) . CONCLUSION: In this cohort of women that had biweekly ultrasounds, most cases of TTTS were detected at an advanced stage (Quintero stage > I). This suggests that biweekly US alone is not adequate to diagnose early TTTS. Further research is required to determine whether more frequent US screening may improve early detection. For women diagnosed on first US, it is unclear from this analysis whether earlier US would detect TTTS earlier.
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191 The natural history of selective intrauterine growth restriction in monochorionic-diamniotic twins Table 1 ). Little is known on the natural history of sIUGR based on the Barcelona classification and management recommendations. (Valsky DV 2010) . Here we present a case series of twins with sIUGR as it evolved during gestation. STUDY DESIGN: This is a retrospective cohort study of MCDA twin pregnancies whose first ultrasound examination occurred at our center between 2013 and 2018. Women with uncertain chronicity, less than 2 surveillance ultrasounds at our center, or those followed at an outside location were excluded. Fetuses with twin-twin transfusion syndrome were also excluded. Routine surveillance consisted of an ultrasound every 2 weeks starting at 16 weeks gestational age (GA). sIUGR was defined by growth discordance of 25% or greater and Gratacós stage was determined by UA Doppler flow pattern. We compared gestational age of diagnosis, the perinatal outcome based on the sIUGR type. RESULTS: Of 409 women with MCDA twins that met inclusion criteria, 67 (14.4%) developed sIUGR. Among these, 54 (80.6%) were type I, 9 (13.4%) were type II and, and 4 (6.0%) were type III sIUGR at the time of diagnosis. Diagnoses were made in 28 (42%) at 16 e 20 weeks GA, 16 (24%) at 20 e 24 weeks GA The remaining 23 cases (34%) were detected throughout the third trimester with one diagnosis > 36 weeks GA (Figure 1 ). The majority of type II and III cases (n ¼ 7, 54%) were diagnosed prior to 20 weeks, however GA at diagnosis between types was similar (p ¼ 0.83). Of twins with type I sIUGR 9 (17%) cases resolved spontaneously, whereas 1 (9%) of twins with types II or III appeared to resolve. Rates of demise of the smaller twin were similar between each type of sIUGR (p ¼ 0.46, Table 1 ). For sIUGR types I and II, the disease was more likely to remain unchanged throughout pregnancy (p < 0.01). CONCLUSION: The majority of sIUGR, regardless of type developed prior to 24 weeks GA. Resolution of disease and demise of the small twin appeared to be independent of initial sIUGR type, however this study may be underpowered to detect differences in these rare outcomes. Finally, types I and II sIUGR are more likely to remain the same type throughout pregnancy.
192 Characterizing congenital heart anomalies in pregnancies with single umbilical artery
Corrie Miller, Dena Towner
University of Hawaii, Honolulu, HI OBJECTIVE: Single umbilical artery (SUA) is associated with fetal growth restriction as well as genetic and structural anomalies. Fetal echocardiogram has become a standard of care when a SUA is identified due to this association with congenital heart defects (CHD). This study aimed to characterize the type of CHD associated with SUA, the utility of ECHO after a negative targeted anatomy ultrasound and identify if a CHD was more common if there were non-cardiac anomalies also detected. STUDY DESIGN: Retrospective chart review of all patients with ultrasonographic findings of SUA and pathologic confirmation postnatally between 2010 and 2018 our Fetal Diagnostic Center. The rates and types of CHD in patients with isolated SUA and nonisolated SUA (additional anomalies detected on anatomical survey) were compared. The types of CHD were classified as major (structural) defects or minor (septal defects, anomalous vasculature, malrotation). RESULTS: 299 patients with pathologically confirmed SUA were identified between July 2010 and July 2018. Fifteen (5%) of these were confirmed to have aneuploidy either antenatally or postnatally and were excluded from the analysis. 247 (82.6%) fetuses had isolated SUA, and 37 (12.3%), had another concurrent fetal anomaly.
Of patients with isolated SUA, 4.5% had a congenital heart defect, while 16.2% of fetuses with another anomaly were found to have CHD. Isolated SUA did not confer less risk for major CHD vs. nonisolated SUA, (X 2 ¼ 1.41, p ¼ 0.23). Half of major anomalies were identified at the time of fetal echocardiogram and were not seen at the time of targeted anatomy sonogram.
CONCLUSION:
Even with isolated SUA, the incidence of CHD is increased over the baseline risk of the general population and should warrant additional screening via fetal echocardiogram. Furthermore, the type of CHD can be severe and require referral to a tertiary care center.
193 Individualized Growth Assessment in pregnancies complicated by fetal gastroschisis OBJECTIVE: Fetal gastroschisis is associated with IUGR and SGA. Prenatal US may overcall IUGR because the abdominal circumference and associated weight estimations can be underestimated by herniated viscera. Individualized Growth Assessment (IGA) evaluates fetal and neonatal growth based on serial US measurements, thus is different from conventional methods that use populationbased curves at fixed time points. Our goal was to assess the potential of IGA for separating normal and pathological growth in gastroschisis cases. STUDY DESIGN: Pregnancies with fetal gastroschisis that were managed and delivered at a single academic medical center were analyzed. Cases were classified into four groups by the presence of IUGR and SGA. IUGR was defined as US EFW <10 th percentile by Hadlock formula; SGA was defined as birthweight <10 th percentile by Fenton curve. Second and third trimester US fetal biometry and neonatal measurements were entered into iGAP software, which calculates fetal and neonatal growth pathology scores based on estimates of growth potential from 2 nd trimester growth velocities. Agreement between conventional US methods and IGA was assessed. RESULTS: Of 70 pregnancies with fetal gastroschisis delivered between 2009 and 2016 at a single center, 21 pregnancies with at least four US measurements were included. In the no IUGR/no SGA group (n¼12), there was 75% agreement (9/12) between IGA and conventional methods. IGA reported a negative prenatal growth score in three cases, but all showed a normal neonatal growth score. In the yes IUGR/yes SGA group (n¼5) there was 100% agreement between IGA and conventional methods in assessing prenatal growth restriction. However, IGA reported a negative neonatal growth score in only two (40%) of the cases. In the yes IUGR/no SGA group
